Because of the complex range of factors to be considered in pscyhosis –genetic, neurologic, biologic, environmental, family, culture - this issue of Child and Adolescent Psychiatric Clinics presents aspects that have the greatest relevance and impact in diagnosing and treating child and adolescent patients. Among some of the topics covered: Schizophrenia, Affective disorders and Psychosis, Comorbid diseases, Neurocognition, Genetics, Neuroimaging findings, and Treatment approaches of Psychopharmacology, Psychotherapy, and Community Rehabilitation. Jean Frazier, an expert in child and adolescent neuropsychiatry and in child psychopharmacology, leads this issue along with Yael Dvir, whose research and clinical interests include childhood psychosis and the associations between childhood psychosis and Autistic Spectrum Disorders.

This issue of Child and Adolescent Psychiatric Clinics, guest edited by Drs. Ellen House and John Tyson, will cover key topics of importance surrounding Psychosis in Children and Adolescents. This issue is one of four selected each year by our series Consulting Editor, Dr. Harsh Trivedi. Topics discussed in this issue include but are not limited to: Prodrome, Autism, Trauma, Medical Etiologies, Mood/Anxiety, Childhood onset schizophrenia, Substance Induced, Genetics of childhood onset schizophrenia, Neurocognition in youth with psychosis, Psychopharmacologic approaches, Community Based interventions, Evidence-Based Therapies for psychosis, School based approach to yout

This issue of the Child and Adolescent Psychiatric Clinics of North America, guest edited by Drs. Adele Martel and Catherine Fuchs, aims to bridge the current state of knowledge about risk and resilience during the transition to adolescence for young people with mental illness with the need for developmentally-attuned and culturally–competent strategies to engage and maintain them in treatment. Topics covered in this volume include, but are not limited to: Developmental Psychopathology and Resilience; Conceptualization of Mental Illness in Transitional Age Youth; Suicidal Behaviors and Suicide; Substance Abuse; Working with Parents/Family; Social Media; Youth Transitioning from Foster Care; Heading to College with a Psychiatric Diagnosis; Issues of Diversity, Integrated Identities and Mental Health in Transitional Age Youth; and Autism Spectrum Disorders, among others.

Psychopharmacology is a dominant treatment in child and adolescent psychiatry with proven benefits to young patients. The authors present topics related to PSYCHOPHARMACOLOGY ISSUES: Ethical issues, Treatment planning, Side effects, Neural correlates, and Pharmacogenomics. They address DRUGS FOR SPECIFIC DISEASES: Anxiety, Depression, Eating disorders, Sleep disorders, Psychosis and Schizophrenia, High-risk for bilpolar and schizophrenia, Bipolar, ADHD, and Autism. Each topic presents an Overview of the Disease or Issue, Empirical evidence for ethical issues, Treatment summaries that include dose ranges, side effects, contraindications, and how the drugs are used specifically for a disorder. Treatment in the presence of co-morbid conditions, Long-term evidence, and Conclusions and Future directions complete the presentations. Clinical vignettes are provided that exemplify the main points of the topic.

This issue of Child and Adolescent Psychiatric Clinics, guest edited by Drs. Ellen House and John Tyson, will cover key topics of importance surrounding Psychosis in Children and Adolescents. This issue is one of four selected each year by our series Consulting Editor, Dr. Harsh Trivedi. Topics discussed in this issue include but are not limited to: Prodrome, Autism, Trauma, Medical Etiologies, Mood/Anxiety, Childhood onset schizophrenia, Substance Induced, Genetics of childhood onset schizophrenia, Neurocognition in youth with psychosis, Psychopharmacologic approaches, Community Based interventions, Evidence-Based Therapies for psychosis, School based approach to yout

This publication in Child & Adolescent Psychiatric Clinics is led by two renown psychiatric physicians specializing in Disaster Psychiatry, Trauma, and International Psychiatry for children and adolescents: Dr. Paramjit Joshi and Dr. Lisa Cullins. The audience for this clinically focused resource includes: Child & Adolescent Psychiatrists -Clinical physicians or research PhDs; Mental Health Nurse Practitioners and all Nurses; International Aid Organizations; Religious Counselors; and Psychology Counselors. Each Author in this publication is recognized expert in their own right, who cover topics such as: Bullying: A Global Approach to Prevention; Challenges in Providing Child and Adolescent Psychiatric Services in Low Resource Countries; Child Soldiers; Wealth, Health and the Moderating Role of Implicit Social Class Bias from a Global Perspective; Developing Mental Health Services for child and adolescent psychiatrists after an Earthquake; . Nuclear Disasters; Children Displaced by War: Impact on the Psychological Well-being; Global Perspectives on Teaching and Learning about child and adolescent psychiatry; Partnering and Collaborating for the Word's Children.

These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. There is a worse prognosis for psychosis and schizophrenia when onset is in childhood or adolescence, and this new NICE guideline puts much-needed emphasis on early recognition and assessment of possible psychotic symptoms. For the one-third of children and young people who go on to experience severe impairment as a result of psychosis or schizophrenia the guideline also offers comprehensive advice from assessment and treatment of the first episode through to promoting recovery.This guideline reviews the evidence for recognition and management of psychosis and schizophrenia in children and young people across the care pathway, encompassing access to and delivery of services, experience of care, recognition and management of at-risk mental states, psychological and pharmacological interventions, and improving cognition and enhancing engagement with education and employment.